Cost-effectiveness of the Haemophilus influenzae type b vaccine for infants in mainland China

References

• Hamborsky J, Kroger A, Wolfe C. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Washington D.C: Public Health Foundation; 2015.
   Google Scholar
• Watt JP, Wolfson LJ, O'Brien KL, Henkle E, Deloria-Knoll M, McCall N, Lee E, Levine OS, Hajjeh R, Mulholland K, et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: Gglobal estimates. Lancet. 2009;374(9693):903–11. doi:10.1016/S0140-6736(09)61203-4. PMID:19748399.
   PubMed Web of Science ®Google Scholar
• Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: A meta-analysis. Pediatr Infect Dis J. 1993;12(5):389–94. doi:10.1097/00006454-199305000-00008. PMID:8327300.
   PubMed Web of Science ®Google Scholar
• WHO. Haemophilus influenzae type b (Hib) Vaccination WHO position paper: July 2013-Recommendations. Vaccine. 2013;31(52):6168–9. doi:10.1016/j.vaccine.2013.10.045. PMID:24156921.
   PubMed Web of Science ®Google Scholar
• Watt JP, Chen S, Santosham M. Haemophilus influenzae type b conjugate vaccine: Review of observational data on long term vaccine impact to inform recommendations for vaccine schedule. 2012 [ accessed March 2, 2017]. http://cdrwww.who.int/immunization/sage/meetings/2013/april/4_Hib_Review_observational_data_Watt.pdf.
   Google Scholar
• Ping Y, Yaling J, Jingshan Z, Lei C, Lingsheng C, Jian C, Qiyou X, Huaqing W. Surveillance of Category II Vaccines in China, 2014. Chinese Journal of Vaccines and Immunization. 2016;22(2):143-148+158.
   Google Scholar
• Whitney CG, Klugman KP. Vaccines as tools against resistance: the example of pneumococcal conjugate vaccine. Seminars in pediatric infectious diseases. 2004;15(2):86–93. doi:10.1053/j.spid.2004.01.011. PMID:15185191.
   PubMedGoogle Scholar
• Yang YH, Fu SG, Peng H, Shen AD, Yue SJ, Go YF, Yuan L, Jiang ZF. Abuse of antibiotics in China and its potential interference in determining the etiology of pediatric bacterial diseases. Pediatr Infect Dis J. 1993;12(12):986–8. doi:10.1097/00006454-199312000-00004. PMID:8108225.
   PubMed Web of Science ®Google Scholar
• Griffiths UK, Clark A, Hajjeh R. Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in low- and middle-income countries: Regional analysis and assessment of major determinants. J Pediatr. 2013;163(1):S50-S9 e9. doi:10.1016/j.jpeds.2013.03.031.
   Web of Science ®Google Scholar
• Le P, Griffiths UK, Anh DD, Franzini L, Chan W, Swint JM. Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam. Vaccine. 2015;33(36):4639–46. doi:10.1016/j.vaccine.2015.05.050. PMID:26044493.
   PubMed Web of Science ®Google Scholar
• Broughton EI. Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: A cost-effectiveness analysis. J Public Health (Oxf). 2007;29(4):441–8. doi:10.1093/pubmed/fdm055. PMID:17875589.
   PubMed Web of Science ®Google Scholar
• Gupta M, Prinja S, Kumar R, Kaur M. Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India. Health Policy Plan. 2013;28(1):51–61. doi:10.1093/heapol/czs025. PMID:22407018.
   PubMed Web of Science ®Google Scholar
• Xiaoping H. Cost-Effectiveness Analysis of Hib Vaccination Program in Taiwan. 1994 [ accessed May 3, 2017]. http://www.cdc.gov.tw/uploads/files/4e94658b-c9f2-4661-ae45-3bbd48d85fd3.pdf.
   Google Scholar
• Ziying S. Cost-Effectiveness Analysis of Hemophilus influenzae type b (Hib) Vaccination under 5 years of age in Taiwan[dissertation]. Tainan: Chang Jung Christian University; 2007.
   Google Scholar
• Department of Immunization, Vaccines and Biologicals. WHO guide for standardization of economic evaluations of immunization programmes. Geneva: WHO Press; 2008.
   Google Scholar
• Zhao D, Gai Tobe R, Cui M, He J, Wu B. Cost-effectiveness of a 23-valent pneumococcal polysaccharide vaccine immunization programme for the elderly in Shanghai, China. Vaccine. 2016;34(50):6158–65. doi:10.1016/j.vaccine.2016.11.003. PMID:27838068.
   PubMed Web of Science ®Google Scholar
• Wu DB, Roberts C, Lee VW, Hong LW, Tan KK, Mak V, Lee, K K. Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong. Hum Vaccin Immunother. 2016;12(2):403–16. doi:10.1080/21645515.2015.1067351. PMID:26451658.
   PubMed Web of Science ®Google Scholar
• van Hoek AJ, Miller E. Cost-Effectiveness of Vaccinating Immunocompetent >/ = 65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England. PLoS One. 2016;11(2):e0149540. doi:10.1371/journal.pone.0149540. PMID:26914907.
   PubMed Web of Science ®Google Scholar
• Newall AT, Reyes JF, McIntyre P, Menzies R, Beutels P, Wood JG. Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: Uncertain herd impact on pneumonia critical. Vaccine. 2016;34(3):320–7. doi:10.1016/j.vaccine.2015.11.053. PMID:26657187.
   PubMed Web of Science ®Google Scholar
• Maurer KA, Chen HF, Wagner AL, Hegde ST, Patel T, Boulton ML, Hutton, D W. Cost-effectiveness analysis of pneumococcal vaccination for infants in China. Vaccine. 2016;34(50):6343–49. doi:10.1016/j.vaccine.2016.10.051. PMID:27810315.
   PubMed Web of Science ®Google Scholar
• Delgleize E, Leeuwenkamp O, Theodorou E, Van de Velde N. Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: A comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model. BMJ Open. 2016;6(11):e010776. doi:10.1136/bmjopen-2015-010776. PMID:27903558.
   PubMed Web of Science ®Google Scholar
• Plotkin SA, Orenstein WA, Offit PA. Vaccine. Philadelphia, PA: Elsevier; 2013.
   Google Scholar
• Sassi F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan. 2006;21(5):402–8. doi:10.1093/heapol/czl018. PMID:16877455.
   PubMed Web of Science ®Google Scholar
• UNICEF. Vaccine Price Data. 2017 [ accessed March 2 2017]. https://www.unicef.org/supply/files/DTP-HepB-Hib.pdf.
   Google Scholar
• Ministry of Finance of the People's Republic of China. Subsidies of public health service, 2016. Beijing: 2016 [accessed March 2 2017]. http://sbs.mof.gov.cn/zxzyzf/ggwsfwbzzj/201607/t20160721_2367374.html.
   Google Scholar
• National Health and Family Planning Commission of the PRC. China Health and Family Planning Statistical Yearbook. Beijing: Peking Union Medical College Press; 2016.
   Google Scholar
• Guijun N, Xuxia W, Shiwen L, Yuying Z, Bingling Z, Xiaoshu Z, Yixing L, Zundong Y, Weizhong Y. Retrospective Investigation on Diseases Burden of Children with Community Acquired Pneumonia under 5 Years in Baiyin City of Gansu Province, 2015–2016. Chinese Journal of Vaccines and Immunization. 2017;23(1):18-21+12.
   Google Scholar
• Jinfang S, Hongyan Y, Shicheng Y, Yuehua H, Qiqi W, Wandi P, Maigeng Z, Shiwei L, Yichong L. Disease Burden of three kinds of bacterial meningitis in China, 1990 and 2010. Disease Surveillance. 2015;30(12):1008–13.
   Google Scholar
• Wenting L. Study on economic burden of bacterial meningitis in China[dissertation]. Beijing: Chinese Center for Disease Control and Prevention; 2016.
   Google Scholar
• Bingkui S. Investigation on neonatal hearing screening status in Zhengzhou, 2009–2013. Maternal and Child Health Care of China. 2015;30(4):571–3.
   Google Scholar
• Takeuchi M, Yasunaga H, Horiguchi H, Fushimi K. The burden of epiglottitis among Japanese children before the Haemophilus influenzae type b vaccination era: An analysis using a nationwide administrative database. Journal of infection and chemotherapy: Official journal of the Japan Society of Chemotherapy. 2013;19(5):876–9. doi:10.1007/s10156-013-0585-x. PMID:23512615.
   PubMed Web of Science ®Google Scholar
• Kessler A, Wetmore RF, Marsh RR. Childhood epiglottitis in recent years. Int J Pediatr Otorhinolaryngol. 1993;25(1-3):155–62. doi:10.1016/0165-5876(93)90049-9. PMID:8436460.
   PubMed Web of Science ®Google Scholar
• Yin Z, Beeler Asay GR, Zhang L, Li Y, Zuo S, Hutin YJ, Ning G, Sandhu HS, Cairns L, Luo H, et al. An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China. Vaccine. 2012;30(37):5569–77. doi:10.1016/j.vaccine.2012.05.068. PMID:22698453.
   PubMed Web of Science ®Google Scholar
• Huanzhong X, Changwei Q. Educational statistics yearbook of China. 2015. Beijing: China Statistics Press; 2016.
   Google Scholar
• National Bureau of Statistics of China. China Statistical Yearbooks. Beijing: 2016 [accessed Feb 20, 2017].http://www.stats.gov.cn/english/Statisticaldata/AnnualData/.
   Google Scholar
• The People's Bank of China. Exchange Rate. 2017 [ accessed Apirl 20, 2017]. http://www.pbc.gov.cn/diaochatongjisi/resource/cms/2017/01/2017011816584588958.pdf.
   Google Scholar
• Guoen L, Shanlian H, Jiuhon W. China Guidelines for Pharmacoeconomic Evaluations. China Journal of Pharmaceutical Economics. 2011; 30(S3):3-50.
   Google Scholar
• Lei C, Huaqing W, Jinghan Z, Ping Y, Lingsheng C, Guomin Z, Keyu J. National Immunization Coverage Survey in China after Integrated more Vaccines into EPI Since 2008. Chinese Journal of Vaccines and Immunization. 2012;18(5):419-424+478.
   Google Scholar
• O'Loughlin RE, Edmond K, Mangtani P, Cohen AL, Shetty S, Hajjeh R, Mulholland K. Methodology and measurement of the effectiveness of Haemophilus influenzae type b vaccine: Ssystematic review. Vaccine. 2010;28(38):6128–36. doi:10.1016/j.vaccine.2010.06.107.
   PubMed Web of Science ®Google Scholar
• Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S, Oluwalana C, Obaro S, Weber M, Corrah T, et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: A prospective study. Lancet. 2005;366(9480):144–50. doi:10.1016/S0140-6736(05)66788-8. PMID:16005337.
   PubMed Web of Science ®Google Scholar
• Dagan R, Fraser D, Roitman M, Slater P, Anis E, Ashkenazi S, Kassis I, Miron D, Leventhal A. Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b. The Israeli Pediatric Bacteremia and Meningitis Group. Vaccine. 1999;17(2):134–41. doi:10.1016/S0264-410X(98)00165-0. PMID:9987147.
   PubMed Web of Science ®Google Scholar
• Ray GT, Whitney CG, Fireman BH, Ciuryla V, Black SB. Cost-effectiveness of pneumococcal conjugate vaccine: Evidence from the first 5 years of use in the United States incorporating herd effects. Pediatr Infect Dis J. 2006;25(6):494–501. doi:10.1097/01.inf.0000222403.42974.8b. PMID:16732146.
   PubMed Web of Science ®Google Scholar
• Tyo KR, Rosen MM, Zeng W, Yap M, Pwee KH, Ang LW, Shepard DS. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: Comparing estimates for 7-valent, 10-valent, and 13-valent vaccines. Vaccine. 2011;29(38):6686–94. doi:10.1016/j.vaccine.2011.06.091. PMID:21745516.
   PubMed Web of Science ®Google Scholar
• Bennett JE, Sumner W, 2nd, Downs SM, Jaffe DM. Parents' utilities for outcomes of occult bacteremia. Arch Pediatr Adolesc Med. 2000;154(1):43–48. PMID:10632249.
   PubMedGoogle Scholar
• Oostenbrink R, HA AM, Essink-Bot ML. The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: A head-to-head comparison. J Clin Epidemiol. 2002;55(8):791–99. doi:10.1016/S0895-4356(02)00448-1. PMID:12384194.
   PubMed Web of Science ®Google Scholar
• Maurer KA, Chen HF, Wagner AL, Hegde ST, Patel T, Boulton ML, Hutton DW. Cost-effectiveness analysis of pneumococcal vaccination for infants in China. Vaccine. 2016;34(50):6343–49. doi:10.1016/j.vaccine.2016.10.051. PMID:27810315.
   PubMed Web of Science ®Google Scholar
• Melegaro A, Edmunds WJ. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales. Vaccine. 2004;22(31-32):4203–14. doi:10.1016/j.vaccine.2004.05.003. PMID:15474710.
   PubMed Web of Science ®Google Scholar
• WHO-CHOICE. Threshold values for intervention cost-effectiveness by Region. 2005 [ accessed Feb 7, 2017]. http://www.who.int/choice/costs/CER_levels/en/.
   Google Scholar
• Qiu J, Yu C, Ariyaratne TV, Foteff C, Ke Z, Sun Y, Zhang L, Qin F, Sanderson G. Cost-Effectiveness of Pediatric Cochlear Implantation in Rural China. Otol Neurotol. 2017;38(6):e75–e84. doi:10.1097/MAO.0000000000001389. PMID:28379918
   PubMed Web of Science ®Google Scholar
• Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: A systematic review and meta-analysis. Lancet Infectious diseases. 2010;10(5):317–328. doi:10.1016/S1473-3099(10)70048-7. PMID:20417414
   PubMed Web of Science ®Google Scholar
• Yang Y, Leng Z, Lu D. Pediatric Haemophilus influenzae type b meninngitis in Hefei city: an epidemiologic study. National Medical Journal of China. 1998;78(4):251–253. PMID:10923476
   PubMedGoogle Scholar